{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:54:03Z","timestamp":1792814043752,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00467-021-05246-x","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T23:24:29Z","timestamp":1629415469000},"page":"1495-1509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Monogenic forms of low-renin hypertension: clinical and molecular insights"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8753-1837","authenticated-orcid":false,"given":"Priyanka","family":"Khandelwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Deinum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"5246_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41569-020-00466-4","volume":"18","author":"S Padmanabhan","year":"2021","unstructured":"Padmanabhan S, Dominiczak AF (2021) Genomics of hypertension: the road to precision medicine. Nat Rev Cardiol 18:235\u2013250","journal-title":"Nat Rev Cardiol"},{"key":"5246_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s40620-019-00684-1","volume":"33","author":"GM Rossi","year":"2020","unstructured":"Rossi GM, Regolisti G, Peyronel F, Fiaccadori E (2020) Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: a review of the relevant physiology. J Nephrol 33:431\u2013445","journal-title":"J Nephrol"},{"key":"5246_CR3","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00431-011-1440-7","volume":"171","author":"GD Simonetti","year":"2012","unstructured":"Simonetti GD, Mohaupt MG, Bianchetti MG (2012) Monogenic forms of hypertension. Eur J Pediatr 171:1433\u20131439","journal-title":"Eur J Pediatr"},{"key":"5246_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00467-007-0537-8","volume":"24","author":"VM Vehaskari","year":"2009","unstructured":"Vehaskari VM (2009) Heritable forms of hypertension. Pediatr Nephrol 24:1929\u20131937","journal-title":"Pediatr Nephrol"},{"key":"5246_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","volume":"50","author":"FL Fernandes-Rosa","year":"2018","unstructured":"Fernandes-Rosa FL, Daniil G, Orozco IJ, Goppner C, El Zein R, Jain V, Boulkroun S, Jeunemaitre X, Amar L, Lefebvre H, Schwarzmayr T, Strom TM, Jentsch TJ, Zennaro MC (2018) A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nat Genet 50:355\u2013361","journal-title":"Nat Genet"},{"key":"5246_CR6","doi-asserted-by":"crossref","unstructured":"Scholl UI, Stolting G, Schewe J, Thiel A, Tan H, Nelson-Williams C, Vichot AA, Jin SC, Loring E, Untiet V, Yoo T, Choi J, Xu S, Wu A, Kirchner M, Mertins P, Rump LC, Onder AM, Gamble C, McKenney D, Lash RW, Jones DP, Chune G, Gagliardi P, Choi M, Gordon R, Stowasser M, Fahlke C, Lifton RP (2018) CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat Genet 50:349\u2013354","DOI":"10.1038\/s41588-018-0048-5"},{"key":"5246_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11154-018-9481-0","volume":"20","author":"N Pons Fernandez","year":"2019","unstructured":"Pons Fernandez N, Moreno F, Morata J, Moriano A, Leon S, De Mingo C, Zuniga A, Calvo F (2019) Familial hyperaldosteronism type III a novel case and review of literature. Rev Endocr Metab Disord 20:27\u201336","journal-title":"Rev Endocr Metab Disord"},{"key":"5246_CR8","doi-asserted-by":"publisher","first-page":"e06315","DOI":"10.7554\/eLife.06315","volume":"4","author":"UI Scholl","year":"2015","unstructured":"Scholl UI, Stolting G, Nelson-Williams C, Vichot AA, Choi M, Loring E, Prasad ML, Goh G, Carling T, Juhlin CC, Quack I, Rump LC, Thiel A, Lande M, Frazier BG, Rasoulpour M, Bowlin DL, Sethna CB, Trachtman H, Fahlke C, Lifton RP (2015) Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife 4:e06315","journal-title":"Elife"},{"key":"5246_CR9","doi-asserted-by":"crossref","unstructured":"Daniil G, Fernandes-Rosa FL, Chemin J, Blesneac I, Beltrand J, Polak M, Jeunemaitre X, Boulkroun S, Amar L, Strom TM, Lory P, Zennaro MC (2016) CACNA1H mutations are associated with different forms of primary aldosteronism. EBioMedicine 13:225\u2013236","DOI":"10.1016\/j.ebiom.2016.10.002"},{"key":"5246_CR10","doi-asserted-by":"publisher","first-page":"e229031","DOI":"10.1136\/bcr-2018-229031","volume":"12","author":"K Wulczyn","year":"2019","unstructured":"Wulczyn K, Perez-Reyes E, Nussbaum RL, Park M (2019) Primary aldosteronism associated with a germline variant in CACNA1H. BMJ Case Rep 12:e229031","journal-title":"BMJ Case Rep"},{"key":"5246_CR11","first-page":"1109","volume":"95","author":"DJ Sutherland","year":"1966","unstructured":"Sutherland DJ, Ruse JL, Laidlaw JC (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 95:1109\u20131119","journal-title":"Can Med Assoc J"},{"key":"5246_CR12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1046\/j.1440-1681.2001.03574.x","volume":"28","author":"M Stowasser","year":"2001","unstructured":"Stowasser M, Gunasekera TG, Gordon RD (2001) Familial varieties of primary aldosteronism. Clin Exp Pharmacol Physiol 28:1087\u20131090","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"5246_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (1992) A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262\u2013265","journal-title":"Nature"},{"key":"5246_CR14","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/S0021-9258(18)34909-3","volume":"257","author":"MD Chu","year":"1982","unstructured":"Chu MD, Ulick S (1982) Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldosteronism. J Biol Chem 257:2218\u20132224","journal-title":"J Biol Chem"},{"key":"5246_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1067\/mpd.2001.112648","volume":"138","author":"RG Dluhy","year":"2001","unstructured":"Dluhy RG, Anderson B, Harlin B, Ingelfinger J, Lifton R (2001) Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood. J Pediatr 138:715\u2013720","journal-title":"J Pediatr"},{"key":"5246_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.jhh.1001636","volume":"18","author":"F Fallo","year":"2004","unstructured":"Fallo F, Pilon C, Williams TA, Sonino N, Morra Di Cella S, Veglio F, De Iasio R, Montanari P, Mulatero P (2004) Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism. J Hum Hypertens 18:47\u201351","journal-title":"J Hum Hypertens"},{"key":"5246_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","volume":"31","author":"WR Litchfield","year":"1998","unstructured":"Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG (1998) Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31:445\u2013450","journal-title":"Hypertension"},{"key":"5246_CR18","first-page":"1507","volume":"82","author":"WR Litchfield","year":"1997","unstructured":"Litchfield WR, Coolidge C, Silva P, Lifton RP, Fallo F, Williams GH, Dluhy RG (1997) Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 82:1507\u20131510","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1590\/S0004-27302004000500014","volume":"48","author":"GT McMahon","year":"2004","unstructured":"McMahon GT, Dluhy RG (2004) Glucocorticoid-remediable aldosteronism. Arq Bras Endocrinol Metabol 48:682\u2013686","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"5246_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.111.180513","volume":"59","author":"CA Carvajal","year":"2012","unstructured":"Carvajal CA, Campino C, Martinez-Aguayo A, Tichauer JE, Bancalari R, Valdivia C, Trejo P, Aglony M, Baudrand R, Lagos CF, Mellado C, Garcia H, Fardella CE (2012) A new presentation of the chimeric CYP11B1\/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern. Hypertension 59:85\u201391","journal-title":"Hypertension"},{"key":"5246_CR21","first-page":"3570","volume":"82","author":"WR Litchfield","year":"1997","unstructured":"Litchfield WR, New MI, Coolidge C, Lifton RP, Dluhy RG (1997) Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 82:3570\u20133573","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR22","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/01.HYP.38.3.688","volume":"38","author":"L Mosso","year":"2001","unstructured":"Mosso L, Gomez-Sanchez CE, Foecking MF, Fardella C (2001) Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives. Hypertension 38:688\u2013691","journal-title":"Hypertension"},{"key":"5246_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/01.crd.0000096417.42861.ce","volume":"12","author":"GT McMahon","year":"2004","unstructured":"McMahon GT, Dluhy RG (2004) Glucocorticoid-remediable aldosteronism. Cardiol Rev 12:44\u201348","journal-title":"Cardiol Rev"},{"key":"5246_CR24","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-17-0563","volume":"178","author":"JWM Lenders","year":"2018","unstructured":"Lenders JWM, Williams TA, Reincke M, Gomez-Sanchez CE (2018) Diagnosis of endocrine disease: 18-oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids? Eur J Endocrinol 178:R1\u2013R9","journal-title":"Eur J Endocrinol"},{"key":"5246_CR25","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1210\/jcem.86.10.7920","volume":"86","author":"CE Fardella","year":"2001","unstructured":"Fardella CE, Pinto M, Mosso L, Gomez-Sanchez C, Jalil J, Montero J (2001) Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1\/CYP11B2 gene. J Clin Endocrinol Metab 86:4805\u20134807","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR26","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1210\/jcem.83.7.4946","volume":"83","author":"P Mulatero","year":"1998","unstructured":"Mulatero P, Veglio F, Pilon C, Rabbia F, Zocchi C, Limone P, Boscaro M, Sonino N, Fallo F (1998) Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab 83:2573\u20132575","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1445-5994.1997.tb00999.x","volume":"27","author":"M Stowasser","year":"1997","unstructured":"Stowasser M, Gartside MG, Gordon RD (1997) A PCR-based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type I. Aust NZ J Med 27:685\u2013690","journal-title":"Aust NZ J Med"},{"key":"5246_CR28","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1210\/jcem.84.12.6256","volume":"84","author":"RG Dluhy","year":"1999","unstructured":"Dluhy RG, Lifton RP (1999) Glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 84:4341\u20134344","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ecl.2011.01.012","volume":"40","author":"F Halperin","year":"2011","unstructured":"Halperin F, Dluhy RG (2011) Glucocorticoid-remediable aldosteronism. Endocrinol Metab Clin N Am 40:333\u2013341 viii","journal-title":"Endocrinol Metab Clin N Am"},{"key":"5246_CR30","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbadis.2017.12.034","volume":"1864","author":"T Yang","year":"2018","unstructured":"Yang T, He M, Hu C (2018) Regulation of aldosterone production by ion channels: from basal secretion to primary aldosteronism. Biochim Biophys Acta Mol Basis Dis 1864:871\u2013881","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"5246_CR31","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"Choi M, Scholl UI, Yue P, Bjorklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Akerstrom G, Wang W, Carling T, Lifton RP (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768\u2013772","journal-title":"Science"},{"key":"5246_CR32","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/ng.2695","volume":"45","author":"UI Scholl","year":"2013","unstructured":"Scholl UI, Goh G, Stolting G, de Oliveira RC, Choi M, Overton JD, Fonseca AL, Korah R, Starker LF, Kunstman JW, Prasad ML, Hartung EA, Mauras N, Benson MR, Brady T, Shapiro JR, Loring E, Nelson-Williams C, Libutti SK, Mane S, Hellman P, Westin G, Akerstrom G, Bjorklund P, Carling T, Fahlke C, Hidalgo P, Lifton RP (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45:1050\u20131054","journal-title":"Nat Genet"},{"key":"5246_CR33","doi-asserted-by":"publisher","first-page":"C21","DOI":"10.1530\/EJE-19-0688","volume":"181","author":"UI Scholl","year":"2019","unstructured":"Scholl UI (2019) CLCN2 clicks with aldosterone-producing adenomas, too! Eur J Endocrinol 181:C21\u2013C22","journal-title":"Eur J Endocrinol"},{"key":"5246_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","volume":"75","author":"K Nanba","year":"2020","unstructured":"Nanba K, Blinder AR, Rege J, Hattangady NG, Else T, Liu CJ, Tomlins SA, Vats P, Kumar-Sinha C, Giordano TJ, Rainey WE (2020) Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma. Hypertension 75:645\u2013649","journal-title":"Hypertension"},{"key":"5246_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0337-9","volume":"51","author":"E Seidel","year":"2019","unstructured":"Seidel E, Schewe J, Scholl UI (2019) Genetic causes of primary aldosteronism. Exp Mol Med 51:1\u201312","journal-title":"Exp Mol Med"},{"key":"5246_CR36","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1210\/en.2016-1170","volume":"157","author":"EN Reimer","year":"2016","unstructured":"Reimer EN, Walenda G, Seidel E, Scholl UI (2016) CACNA1H(M1549V) mutant calcium channel causes autonomous aldosterone production in HAC15 cells and is inhibited by mibefradil. Endocrinology 157:3016\u20133022","journal-title":"Endocrinology"},{"key":"5246_CR37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/ng0895-394","volume":"10","author":"T Mune","year":"1995","unstructured":"Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC (1995) Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 10:394\u2013399","journal-title":"Nat Genet"},{"key":"5246_CR38","doi-asserted-by":"publisher","first-page":"E11248","DOI":"10.1073\/pnas.1716621115","volume":"114","author":"M Yau","year":"2017","unstructured":"Yau M, Haider S, Khattab A, Ling C, Mathew M, Zaidi S, Bloch M, Patel M, Ewert S, Abdullah W, Toygar A, Mudryi V, Al Badi M, Alzubdi M, Wilson RC, Al Azkawi HS, Ozdemir HN, Abu-Amer W, Hertecant J, Razzaghy-Azar M, Funder JW, Al Senani A, Sun L, Kim SM, Yuen T, Zaidi M, New MI (2017) Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11beta-hydroxysteroid dehydrogenase type 2 deficiency. Proc Natl Acad Sci U S A 114:E11248\u2013E11256","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5246_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4419-8002-1_10","volume":"707","author":"S Nimkarn","year":"2011","unstructured":"Nimkarn S (2011) Apparent mineralocorticoid excess - update. Adv Exp Med Biol 707:47\u201348","journal-title":"Adv Exp Med Biol"},{"key":"5246_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jsbmb.2016.03.010","volume":"165","author":"JW Funder","year":"2017","unstructured":"Funder JW (2017) Apparent mineralocorticoid excess. J Steroid Biochem Mol Biol 165:151\u2013153","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5246_CR41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12020-020-02460-9","volume":"70","author":"P Fan","year":"2020","unstructured":"Fan P, Lu YT, Yang KQ, Zhang D, Liu XY, Tian T, Luo F, Wang LP, Ma WJ, Liu YX, Zhang HM, Song L, Cai J, Lou Y, Zhou XL (2020) Apparent mineralocorticoid excess caused by novel compound heterozygous mutations in HSD11B2 and characterized by early-onset hypertension and hypokalemia. Endocrine 70:607\u2013615","journal-title":"Endocrine"},{"key":"5246_CR42","first-page":"2263","volume":"80","author":"RC Wilson","year":"1995","unstructured":"Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei JQ, Shackleton CH, Funder JW, New MI (1995) A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80:2263\u20132266","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR43","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1681\/ASN.2006060570","volume":"17","author":"G Morineau","year":"2006","unstructured":"Morineau G, Sulmont V, Salomon R, Fiquet-Kempf B, Jeunemaitre X, Nicod J, Ferrari P (2006) Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. J Am Soc Nephrol 17:3176\u20133184","journal-title":"J Am Soc Nephrol"},{"key":"5246_CR44","doi-asserted-by":"publisher","first-page":"E821","DOI":"10.1210\/jc.2013-3254","volume":"99","author":"SL Rogers","year":"2014","unstructured":"Rogers SL, Hughes BA, Jones CA, Freedman L, Smart K, Taylor N, Stewart PM, Shackleton CH, Krone NP, Blissett J, Tomlinson JW (2014) Diminished 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased weight and weight gain across the first year of life. J Clin Endocrinol Metab 99:E821\u2013E831","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR45","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1590\/S0004-27302004000500015","volume":"48","author":"M Palermo","year":"2004","unstructured":"Palermo M, Quinkler M, Stewart PM (2004) Apparent mineralocorticoid excess syndrome: an overview. Arq Bras Endocrinol Metabol 48:687\u2013696","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"5246_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s004670000377","volume":"15","author":"A Moudgil","year":"2000","unstructured":"Moudgil A, Rodich G, Jordan SC, Kamil ES (2000) Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome. Pediatr Nephrol 15:60\u201362","journal-title":"Pediatr Nephrol"},{"key":"5246_CR47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12098-020-03516-4","volume":"88","author":"M Yadav","year":"2021","unstructured":"Yadav M, Sinha A, Hari P, Bagga A (2021) Impaired distal tubular acidification, renal cysts and nephrocalcinosis in monogenic hypertension. Indian J Pediatr 88:579\u2013581","journal-title":"Indian J Pediatr"},{"key":"5246_CR48","doi-asserted-by":"publisher","first-page":"p23","DOI":"10.1159\/000320117","volume":"116","author":"D Bockenhauer","year":"2010","unstructured":"Bockenhauer D, van't Hoff W, Dattani M, Lehnhardt A, Subtirelu M, Hildebrandt F, Bichet DG (2010) Secondary nephrogenic diabetes insipidus as a complication of inherited renal diseases. Nephron Physiol 116:p23\u2013p29","journal-title":"Nephron Physiol"},{"key":"5246_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF03343803","volume":"24","author":"M Palermo","year":"2001","unstructured":"Palermo M, Delitala G, Mantero F, Stewart PM, Shackleton CH (2001) Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone. J Endocrinol Investig 24:17\u201323","journal-title":"J Endocrinol Investig"},{"key":"5246_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.etap.2017.02.021","volume":"52","author":"C Zhou","year":"2017","unstructured":"Zhou C, Ye F, Wu H, Ye H, Chen Q (2017) Recent advances in the study of 11beta-Hydroxysteroid dehydrogenase type 2 (11beta-HSD2) inhibitors. Environ Toxicol Pharmacol 52:47\u201353","journal-title":"Environ Toxicol Pharmacol"},{"key":"5246_CR51","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41371-017-0002-5","volume":"32","author":"L Hinz","year":"2018","unstructured":"Hinz L, Pacaud D, Kline G (2018) Congenital adrenal hyperplasia causing hypertension: an illustrative review. J Hum Hypertens 32:150\u2013157","journal-title":"J Hum Hypertens"},{"key":"5246_CR52","first-page":"3797","volume":"81","author":"K Miura","year":"1996","unstructured":"Miura K, Yasuda K, Yanase T, Yamakita N, Sasano H, Nawata H, Inoue M, Fukaya T, Shizuta Y (1996) Mutation of cytochrome P-45017 alpha gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17. J Clin Endocrinol Metab 81:3797\u20133801","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR53","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1055\/s-0032-1321851","volume":"44","author":"E Melcescu","year":"2012","unstructured":"Melcescu E, Phillips J, Moll G, Subauste JS, Koch CA (2012) 11Beta-hydroxylase deficiency and other syndromes of mineralocorticoid excess as a rare cause of endocrine hypertension. Horm Metab Res 44:867\u2013878","journal-title":"Horm Metab Res"},{"key":"5246_CR54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1515\/jpem-2018-0298","volume":"32","author":"T Breil","year":"2019","unstructured":"Breil T, Yakovenko V, Inta I, Choukair D, Klose D, Mittnacht J, Schulze E, Alrajab A, Grulich-Henn J, Bettendorf M (2019) Typical characteristics of children with congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency: a single-Centre experience and review of the literature. J Pediatr Endocrinol Metab 32:259\u2013267","journal-title":"J Pediatr Endocrinol Metab"},{"key":"5246_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsbmb.2015.02.007","volume":"150","author":"M Zhang","year":"2015","unstructured":"Zhang M, Sun S, Liu Y, Zhang H, Jiao Y, Wang W, Li X (2015) New, recurrent, and prevalent mutations: clinical and molecular characterization of 26 Chinese patients with 17alpha-hydroxylase\/17,20-lyase deficiency. J Steroid Biochem Mol Biol 150:11\u201316","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5246_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1210\/jc.2003-031021","volume":"89","author":"M Costa-Santos","year":"2004","unstructured":"Costa-Santos M, Kater CE, Auchus RJ, Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group (2004) Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab 89:49\u201360","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR57","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1210\/jc.2003-030988","volume":"88","author":"RM Martin","year":"2003","unstructured":"Martin RM, Lin CJ, Costa EM, de Oliveira ML, Carrilho A, Villar H, Longui CA, Mendonca BB (2003) P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab 88:5739\u20135746","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR58","doi-asserted-by":"publisher","first-page":"E1933","DOI":"10.1073\/pnas.1621082114","volume":"114","author":"A Khattab","year":"2017","unstructured":"Khattab A, Haider S, Kumar A, Dhawan S, Alam D, Romero R, Burns J, Li D, Estatico J, Rahi S, Fatima S, Alzahrani A, Hafez M, Musa N, Razzghy Azar M, Khaloul N, Gribaa M, Saad A, Charfeddine IB, Bilharinho de Mendonca B, Belgorosky A, Dumic K, Dumic M, Aisenberg J, Kandemir N, Alikasifoglu A, Ozon A, Gonc N, Cheng T, Kuhnle-Krahl U, Cappa M, Holterhus PM, Nour MA, Pacaud D, Holtzman A, Li S, Zaidi M, Yuen T, New MI (2017) Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. Proc Natl Acad Sci U S A 114:E1933\u2013E1940","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5246_CR59","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4274\/jcrpe.0032","volume":"10","author":"AD Kardelen","year":"2018","unstructured":"Kardelen AD, Toksoy G, Bas F, Yavas Abali Z, Gencay G, Poyrazoglu S, Bundak R, Altunoglu U, Avci S, Najafli A, Uyguner O, Karaman B, Basaran S, Darendeliler F (2018) Clinical and genetic findings and follow-up characteristics of six patients with 17-hydroxylase deficiency including two novel mutations. J Clin Res Pediatr Endocrinol 10:206\u2013215","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"5246_CR60","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/EJE-19-0811","volume":"182","author":"G Vitellius","year":"2020","unstructured":"Vitellius G, Lombes M (2020) Genetics in endocrinology: glucocorticoid resistance syndrome. Eur J Endocrinol 182:R15\u2013R27","journal-title":"Eur J Endocrinol"},{"key":"5246_CR61","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1210\/jcem.87.4.8379","volume":"87","author":"BB Mendonca","year":"2002","unstructured":"Mendonca BB, Leite MV, de Castro M, Kino T, Elias LL, Bachega TA, Arnhold IJ, Chrousos GP, Latronico AC (2002) Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab 87:1805\u20131809","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1126\/science.289.5476.119","volume":"289","author":"DS Geller","year":"2000","unstructured":"Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289:119\u2013123","journal-title":"Science"},{"key":"5246_CR63","doi-asserted-by":"publisher","first-page":"T93","DOI":"10.1530\/JOE-17-0089","volume":"234","author":"MC Zennaro","year":"2017","unstructured":"Zennaro MC, Fernandes-Rosa F (2017) 30 years of the mineralocorticoid receptor: mineralocorticoid receptor mutations. J Endocrinol 234:T93\u2013T106","journal-title":"J Endocrinol"},{"key":"5246_CR64","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1073\/pnas.0511184103","volume":"103","author":"KK Knight","year":"2006","unstructured":"Knight KK, Olson DR, Zhou R, Snyder PM (2006) Liddle\u2019s syndrome mutations increase Na+ transport through dual effects on epithelial Na+ channel surface expression and proteolytic cleavage. Proc Natl Acad Sci U S A 103:2805\u20132808","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5246_CR65","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/ijms19030812","volume":"19","author":"M Tetti","year":"2018","unstructured":"Tetti M, Monticone S, Burrello J, Matarazzo P, Veglio F, Pasini B, Jeunemaitre X, Mulatero P (2018) Liddle syndrome: review of the literature and description of a new case. Int J Mol Sci 19:812","journal-title":"Int J Mol Sci"},{"key":"5246_CR66","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00431-011-1581-8","volume":"171","author":"R Bogdanovic","year":"2012","unstructured":"Bogdanovic R, Kuburovic V, Stajic N, Mughal SS, Hilger A, Ninic S, Prijic S, Ludwig M (2012) Liddle syndrome in a Serbian family and literature review of underlying mutations. Eur J Pediatr 171:471\u2013478","journal-title":"Eur J Pediatr"},{"key":"5246_CR67","doi-asserted-by":"publisher","first-page":"F1113","DOI":"10.1152\/ajprenal.00609.2019","volume":"318","author":"G Frindt","year":"2020","unstructured":"Frindt G, Bertog M, Korbmacher C, Palmer LG (2020) Ubiquitination of renal ENaC subunits in vivo. Am J Physiol Renal Physiol 318:F1113\u2013F1121","journal-title":"Am J Physiol Renal Physiol"},{"key":"5246_CR68","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1681\/ASN.2016111163","volume":"28","author":"M Salih","year":"2017","unstructured":"Salih M, Gautschi I, van Bemmelen MX, Di Benedetto M, Brooks AS, Lugtenberg D, Schild L, Hoorn EJ (2017) A missense mutation in the extracellular domain of alpha ENaC causes Liddle syndrome. J Am Soc Nephrol 28:3291\u20133299","journal-title":"J Am Soc Nephrol"},{"key":"5246_CR69","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/10641963.2017.1334799","volume":"40","author":"KQ Yang","year":"2018","unstructured":"Yang KQ, Lu CX, Fan P, Zhang Y, Meng X, Dong XQ, Luo F, Liu YX, Zhang HM, Wu HY, Cai J, Zhang X, Zhou XL (2018) Genetic screening of SCNN1B and SCNN1G genes in early-onset hypertensive patients helps to identify Liddle syndrome. Clin Exp Hypertens 40:107\u2013111","journal-title":"Clin Exp Hypertens"},{"key":"5246_CR70","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ajh\/hpaa037","volume":"33","author":"P Fan","year":"2020","unstructured":"Fan P, Pan XC, Zhang D, Yang KQ, Zhang Y, Tian T, Luo F, Ma WJ, Liu YX, Wang LP, Zhang HM, Song L, Cai J, Zhou XL (2020) Pediatric Liddle syndrome caused by a novel SCNN1G variant in a Chinese family and characterized by early-onset hypertension. Am J Hypertens 33:670\u2013675","journal-title":"Am J Hypertens"},{"key":"5246_CR71","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00467-003-1311-1","volume":"19","author":"L Monnens","year":"2004","unstructured":"Monnens L, Levtchenko E (2004) Distinction between Liddle syndrome and apparent mineralocorticoid excess. Pediatr Nephrol 19:118\u2013119","journal-title":"Pediatr Nephrol"},{"key":"5246_CR72","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00000441-200112000-00002","volume":"322","author":"DG Warnock","year":"2001","unstructured":"Warnock DG (2001) Liddle syndrome: genetics and mechanisms of Na+ channel defects. Am J Med Sci 322:302\u2013307","journal-title":"Am J Med Sci"},{"key":"5246_CR73","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00467-014-2956-7","volume":"30","author":"KM O'Shaughnessy","year":"2015","unstructured":"O'Shaughnessy KM (2015) Gordon syndrome: a continuing story. Pediatr Nephrol 30:1903\u20131908","journal-title":"Pediatr Nephrol"},{"key":"5246_CR74","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/genes10120986","volume":"10","author":"H Mabillard","year":"2019","unstructured":"Mabillard H, Sayer JA (2019) The molecular genetics of Gordon syndrome. Genes (Basel) 10:986","journal-title":"Genes (Basel)"},{"key":"5246_CR75","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1126\/science.1062844","volume":"293","author":"FH Wilson","year":"2001","unstructured":"Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP (2001) Human hypertension caused by mutations in WNK kinases. Science 293:1107\u20131112","journal-title":"Science"},{"key":"5246_CR76","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature10814","volume":"482","author":"LM Boyden","year":"2012","unstructured":"Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol A, Valimaki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR, Keppler-Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB, Bettinelli A, Fadrowski JJ, Belsha CW, Hunley TE, Nelson RD, Trachtman H, Cole TR, Pinsk M, Bockenhauer D, Shenoy M, Vaidyanathan P, Foreman JW, Rasoulpour M, Thameem F, Al-Shahrouri HZ, Radhakrishnan J, Gharavi AG, Goilav B, Lifton RP (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482:98\u2013102","journal-title":"Nature"},{"key":"5246_CR77","doi-asserted-by":"crossref","unstructured":"Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O, Beaurain G, Bonnefond A, Sand O, Simian C, Vidal-Petiot E, Soukaseum C, Mandet C, Broux F, Chabre O, Delahousse M, Esnault V, Fiquet B, Houillier P, Bagnis CI, Koenig J, Konrad M, Landais P, Mourani C, Niaudet P, Probst V, Thauvin C, Unwin RJ, Soroka SD, Ehret G, Ossowski S, Caulfield M, International Consortium for Blood P, Bruneval P, Estivill X, Froguel P, Hadchouel J, Schott JJ, Jeunemaitre X (2012) KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet 44(456\u2013460):S451\u2013S453","DOI":"10.1038\/ng.2218"},{"key":"5246_CR78","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1515\/jpem-2016-0309","volume":"30","author":"JS Park","year":"2017","unstructured":"Park JS, Park E, Hyun HS, Ahn YH, Kang HG, Ha IS, Cheong HI (2017) Three cases of Gordon syndrome with dominant KLHL3 mutations. J Pediatr Endocrinol Metab 30:361\u2013364","journal-title":"J Pediatr Endocrinol Metab"},{"key":"5246_CR79","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1002\/mgg3.705","volume":"7","author":"T Sakoh","year":"2019","unstructured":"Sakoh T, Sekine A, Mori T, Mizuno H, Kawada M, Hiramatsu R, Hasegawa E, Hayami N, Yamanouchi M, Suwabe T, Sawa N, Ubara Y, Fujimaru T, Sohara E, Shinichi U, Hoshino J, Takaichi K (2019) A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4. Mol Genet Genomic Med 7:e705","journal-title":"Mol Genet Genomic Med"},{"key":"5246_CR80","doi-asserted-by":"crossref","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, Subcommittee on screening and management of high blood pressure in children (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904","DOI":"10.1542\/peds.2017-1904"},{"key":"5246_CR81","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","volume":"34","author":"E Lurbe","year":"2016","unstructured":"Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, Rascher W, Redon J, Schaefer F, Seeman T, Sinha M, Stabouli S, Webb NJ, Wuhl E, Zanchetti A (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34:1887\u20131920","journal-title":"J Hypertens"},{"key":"5246_CR82","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/ajh\/hpu083","volume":"28","author":"M Gupta-Malhotra","year":"2015","unstructured":"Gupta-Malhotra M, Banker A, Shete S, Hashmi SS, Tyson JE, Barratt MS, Hecht JT, Milewicz DM, Boerwinkle E (2015) Essential hypertension vs. secondary hypertension among children. Am J Hypertens 28:73\u201380","journal-title":"Am J Hypertens"},{"key":"5246_CR83","doi-asserted-by":"crossref","unstructured":"Gomes RS, Quirino IG, Pereira RM, Vitor BM, Leite AF, Oliveira EA, Simoes e Silva AC (2011) Primary versus secondary hypertension in children followed up at an outpatient tertiary unit. Pediatr Nephrol 26:441\u2013447","DOI":"10.1007\/s00467-010-1712-x"},{"key":"5246_CR84","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.110.168740","volume":"57","author":"M Aglony","year":"2011","unstructured":"Aglony M, Martinez-Aguayo A, Carvajal CA, Campino C, Garcia H, Bancalari R, Bolte L, Avalos C, Loureiro C, Trejo P, Brinkmann K, Giadrosich V, Mericq V, Rocha A, Avila A, Perez V, Inostroza A, Fardella CE (2011) Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation. Hypertension 57:1117\u20131121","journal-title":"Hypertension"},{"key":"5246_CR85","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/jch.12598","volume":"17","author":"LP Wang","year":"2015","unstructured":"Wang LP, Yang KQ, Jiang XJ, Wu HY, Zhang HM, Zou YB, Song L, Bian J, Hui RT, Liu YX, Zhou XL (2015) Prevalence of Liddle syndrome among young hypertension patients of undetermined cause in a Chinese population. J Clin Hypertens (Greenwich) 17:902\u2013907","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"5246_CR86","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/jmedgenet-2019-106145","volume":"57","author":"M Bao","year":"2020","unstructured":"Bao M, Li P, Li Q, Chen H, Zhong Y, Li S, Jin L, Wang W, Chen Z, Zhong J, Geng B, Fan Y, Yang X, Cai J (2020) Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting. J Med Genet 57:571\u2013580","journal-title":"J Med Genet"},{"key":"5246_CR87","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:1889\u20131916","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR88","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ancard.2015.04.017","volume":"64","author":"M Barigou","year":"2015","unstructured":"Barigou M, Ah-Kang F, Orloff E, Amar J, Chamontin B, Bouhanick B (2015) Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension. Ann Cardiol Angeiol (Paris) 64:169\u2013174","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"5246_CR89","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1210\/jc.2004-1149","volume":"90","author":"SC Tiu","year":"2005","unstructured":"Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM, Kong AP (2005) The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 90:72\u201378","journal-title":"J Clin Endocrinol Metab"},{"key":"5246_CR90","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1055\/s-0031-1295460","volume":"44","author":"M Stowasser","year":"2012","unstructured":"Stowasser M, Ahmed AH, Pimenta E, Taylor PJ, Gordon RD (2012) Factors affecting the aldosterone\/renin ratio. Horm Metab Res 44:170\u2013176","journal-title":"Horm Metab Res"},{"key":"5246_CR91","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/HYPERTENSIONAHA.110.155135","volume":"56","author":"A Martinez-Aguayo","year":"2010","unstructured":"Martinez-Aguayo A, Aglony M, Campino C, Garcia H, Bancalari R, Bolte L, Avalos C, Loureiro C, Carvajal CA, Avila A, Perez V, Inostroza A, Fardella CE (2010) Aldosterone, plasma renin activity, and aldosterone\/renin ratio in a normotensive healthy pediatric population. Hypertension 56:391\u2013396","journal-title":"Hypertension"},{"key":"5246_CR92","first-page":"50","volume":"90","author":"V Precone","year":"2019","unstructured":"Precone V, Krasi G, Guerri G, Stuppia L, Romeo F, Perrone M, Marinelli C, Zulian A, Dallavilla T, Bertelli M (2019) Monogenic hypertension. Acta Biomed 90:50\u201352","journal-title":"Acta Biomed"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05246-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05246-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05246-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T08:05:45Z","timestamp":1655107545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05246-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":92,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5246"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05246-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"assertion":[{"value":"8 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}